← The Wire
AVLNNasdaq
Avalyn Pharma Inc.
Pharmaceutical Preparations · DE · CIK 1540171
Develops inhaled medicines for rare respiratory diseases like pulmonary fibrosis
$1.33B
Market cap
$31.00
Last close
+0.9%
1D
-6.0%
5D
350K
Volume
Price · last 39 sessions+6.6%
May 4L $25.72 · H $32.97Jun 29
8
Total filings
Jun 17, 2026
Last filing
12/31
Fiscal year end
8-KReg FD DisclosureJun 17, 202610-Q10-QJun 3, 20268-KResults of OperationsJun 3, 2026SC 13DSC 13DMay 8, 2026SC 13DSC 13DMay 8, 20268-KBylaw AmendmentMay 1, 2026424B4424B4Apr 30, 2026S-1/AS-1/AApr 29, 2026S-1/AS-1/AApr 23, 2026S-1S-1Apr 8, 2026
Similar companies
Comparable business profile · signals at a glance